The utilities of pyrazolines encouraged synthesis of a new pyrazoline derivative via ring closure of chalcone, for optimistic neurodegenerative applications
Keywords:2-Pyrazoline ligands, chalcones, clinical applications, spectroscopic studies
Pyrazolines and their derivatives have been extensively studied as coordinated ligands of high potential applications in diverse chemical and biological systems. This work explores some methods of synthesis of pyrazolines, such as the preparation of pyrazole derivatives via chalcones. It also demonstrates that 2-pyrazoline complexes were biologically active and have had a range of clinical applications. Palladium (II) complex of pyrazole was active as antitumor when tested against murine mammary adenocarcinoma (LM3). Copper (II) and Cobalt (II) complex are biologically active in the living system as biomolecules or co factors. Based on these information, we tried here to synthesis a new 2-pyrazoline from (E)-3-(4-bromophenyl)-1-(pyridin-2-yl)prop-2-en-1-one. The newly synthesized pyrazoline was characterized using mass spectroscopy, nucleic magnetic resonance spectroscopy NMR and Fourier transform infrared spectroscopy FTIR. The characterization results showed that 2-pyrazoline has successfully synthesized. The microanalyses (C.H.N.S), GC-MS, H and 13C NMR and FT-IR spectra confirmed the formation of 2-pyrazoline ring with substitution at N1,C-3 and C-5 and the spin-spin coupling constants (J) for the multiple peaks at H NMR spectra pointed to the de shielded aromatic protons in α and β protons of the prepared chalcone. Interestingly, some new family of pyrazoles that have isosteres of Zonisamide have previously showed activity toward treating neuroglial disorders such as epilepsy and autism. Thus, our synthesized pyrazole could have the potency to moderate some neurodegenerative disorders. It could negatively interact with some neurotransmitters through hydrogen bonding and electrostatic interactions with the amino and carboxylic ends of the functional ends of the neurotransmitters. This promising trend by the promising candidate 2- pyrazoline should have further investigations.
Li JT, Zhang XH, Lin ZP. An improved synthesis of 1,3,5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation. Beilstein J Org Chem. 2007;3:11-20.
M. Nic JJBK. Selectivity:IUPAC. Compendium of Chemical Terminology, (the "Gold Book"). 1997.
Shaaban MR, Mayhoub AS, Farag AM. Recent advances in the therapeutic applications of pyrazolines. Expert Opinion on Therapeutic Patents. 2012;22:253-91.
Onoa GB, Moreno V, Font-Bardia M, Solans X, Pérez JM, Alonso C. Structural and cytotoxic study of new Pt(II) and Pd(II) complexes with the bi-heterocyclic ligand mepirizole. J Inorg Biochem. 1999;75:205-12.
Abid M, Azam A. Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones. Bioorganic Med Chem. 2005;13:2213-20.
Konar S, Jana A, Das K, Ray S, Golen JA, Rheingold AL, et al. A rare pentanuclear cadmium(II) complex and two new mononuclear zinc(II) complexes of pyrazole derived ditopic ligands-Synthesis, crystal structures and spectral studies. Inorganica Chim Acta. 2013;397:144-51.
Bharti N, Shailendra, Sharma S, Naqvi F, Azam A. New palladium(II) complexes of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones: Synthesis, spectral studies and in vitro anti-amoebic activity. Bioorganic Med Chem. 2003;11:2923-9.
Navarro JAR, Lippert B. Simple 1:1 and 1:2 complexes of metal ions with heterocycles as building blocks for discrete molecular as well as polymeric assemblies. Coordination Chemistry Reviews. 2001;222:219-50.
Foye WO, Lemke TL W DA. Color Section. Photosynthesis Research. 2004;80:5-8.
Blumberg WE, Peisach J. The optical and magnetic properties of copper in Chenopodium album plastocyanin. BBA - Biophys Incl Photosynth. 1966;126:269-73.
Matzapetakis M, Dakanali M, Raptopoulou CP, Tangoulis V, Terzis A, Moon N, et al. Synthesis, spectroscopic, and structural characterization of the first aqueous cobalt(II)-citrate complex: Toward a potentially bioavailable form of cobalt in biologically relevant fluids. J Biol Inorg Chem. 2000;5:469-74.
Fioravanti R, Bolasco A, Manna F, Rossi F, Orallo F, Ortuso F, et al. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2- pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Eur J Med Chem. 2010;45:6135-8.
Jadhav SY, Shirame SP, Kulkarni SD, Patil SB, Pasale SK, Bhosale RB. PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents. Bioorganic Med Chem Lett. 2013;23:2575-8.
Acharya BN, Saraswat D, Tiwari M, Shrivastava AK, Ghorpade R, Bapna S, et al. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur J Med Chem. 2010;45:430-8.
Kou X, Shao Q, Ye C, Yang G, Zhang W. Asymmetric Aza-Wacker-Type Cyclization of N-Ts Hydrazine-Tethered Tetrasubstituted Olefins: Synthesis of Pyrazolines Bearing One Quaternary or Two Vicinal Stereocenters. J Am Chem Soc. 2018;140:7587-97.
Kanemasa S, Kanai T. Lewis acid-catalyzed enantioselective 1,3-dipolar cycloadditions of diazoalkane: Chiral ligand/achiral auxiliary cooperative chirality control . Journal of the American Chemical Society. 2000;122:10710-1.
Di Carlo G, Mascolo N, Izzo AA, Capasso F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sciences. 1999;65:337-53.
Donnelly DMX. The Chemistry of Chalcones and Related Compounds. Phytochemistry. 1982;21:2435.
Yusuf M, Jain P. Synthetic and biological studies of pyrazolines and related heterocyclic compounds. Arab J Chem. 2014;7:553-96.
Ashton WT, Doss GA. A regioselective route to 3‐alkyl‐1‐aryl‐1H‐pyrazole‐5‐carboxylates: Synthetic studies and structural assignments. J Heterocycl Chem. 1993;30:307-11.
Turan-Zitouni G, Chevallet P, Kiliç FS, Erol K. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem. 2000;35:635-41.
Fahad ARM, Abid MN. Synthesis, characterization and antimicrobial activity of some transition metals complexes derived from bis-pyrazoline based ligand. Malaysian J Sci. 2019;38:59-71.
Özdemir A. Synthesis and antimicrobial activity of some pyrazoline derivatives bearing amide moiety. Marmara Pharm J. 2013;17:187-92.
Vicentini CB, Manfredini S, Manfrini M, Bazzanini R, Musiu C, Putzolu M, et al. Synthesis and biological evaluation of a series of substituted pyrazolo[3,4-d]-1,2,3-triazoles and pyrazolo[3,4-d]oxazoles. Arch Pharm (Weinheim). 1998;331:269-72.
Annigeri SM, Sathisha MP, Revankar VK. Spectroscopic studies of bridged binuclear complexes of Co(II), Ni(II), Cu(II) and Zn(II). Transit Met Chem. 2007;32:81-7.
Syamal A, Maurya MR. Synthesis and characterisation of nickel(II), cobalt(II), manganese(II), copper(II), zinc(II), dioxouranium(VI) and dioxomolybdenum(VI) complexes of tridentate dibasic ONO donor Schiff bases derived from 2-benzothiazolecarbohydrazide and salicylaldehyde/2. Transit Met Chem. 1986;11:201-5.
Yang TH, Silva AR, Shi FN. Six new 3d-4f heterometallic coordination polymers constructed from pyrazole-bridged CuIILnIII dinuclear units. Dalt Trans. 2013;42:13997-4005.
Ahirwar MK, Gautam N, Shrivastava SP. Synthesis and antimicrobial activity of some pyrazoline derivatives. Asian J Chem. 2010;22:5297-302.
El Sadek MM, Hassan SY, Abdelwahab HE, Yacout GA. Synthesis and bioassay of a new class of furanyl-1,3,4-oxadiazole derivatives. Molecules. 2013;18:8550-62.
Kaplancikli ZA, Turan-Zitouni G, Özdemir A, Revial G. New triazole and triazolothiadiazine derivatives as possible antimicrobial agents. Eur J Med Chem. 2008;43:155-9.
Ali MA, Shaharyar M, Siddiqui AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem. 2007;42:268-75.
Santhi N, Emayavaramban M, Gopi C, Manivannan C, Raguraman A. Green synthesis and antibacterial evaluation of some 2-pyrazoline derivatives. Int J Adv Chem. 2014;2:5-9.
Jainey PJ, Bhat IK. Antitumor, analgesic, and anti-inflammatory activities of synthesized pyrazolines. J Young Pharm. 2012;4:82-7.
Talegaonkar RS, Burghate AS. pH-metric studies on formation constants of the complexes of substituted thiazolyl Schiff's bases with some lanthanide metal ions. J Indian Chem Soc. 2012;89:1585-9.
Amir M, Kumar S. Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines. Indian J Chem - Sect B Org Med Chem. 2005;44:2532-7.
Donnelly D, Geoghegan R, O'Brien C, Philbin E, Wheeler TS. Synthesis of Heterocyclic-Substituted Chromones and Related Compounds as Potential Anticancer Agents. J Med Chem. 1965;8:872-5.
THAKAR KA, GOSWAMI DD, PACHPOR DG. ChemInform Abstract: SYNTHESIS OF FURAL ANALOGS OF SUBSTITUTED FLAVONOIDS. Chem Informationsd. 1974;5:11-4.
Naik AB, Narwade ML. PH-metric studies on formation constants of the complexes of substituted pyrazoles with some lanthanide metal ions and the influence of ionic strengths on complex equilibria in a 70% dioxane-water mixture. Russ J Coord Chem Khimiya. 2009;35:932-7.
Ramteke A, Narwade ML M V. Studies in acoustical properties of chloro subsitituted pyrazoles in different concentration and different perce2ntages in dioxane - water mixture. 4:254-2612. 2012;4:254-61.
Barra C V. , Rocha F V. , Netto AVG, Shimura B, Frem RCG, Mauro AE, et al. New palladium(II) complexes with pyrazole ligands: Part I. Synthesis, spectral and thermal studies, and antitumor evaluation. In: Journal of Thermal Analysis and Calorimetry. 2011. p. 483-8.
Budakoti A, Abid M, Azam A. Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives. Eur J Med Chem. 2007;42:544-51.
Nabati M, Bodaghi-Namileh V. Evaluation of Medicinal Effects of Isoxazole Ring Isosteres on Zonisamide for Autism Treatment by Binding to Potassium Voltage-Gated Channel Subfamily D Member 2 (Kv 4. 2). Adv J Chem A. 2020;3:462-72.
Ali I, Wani WA, Khan A, Haque A, Ahmad A, Saleem K, et al. Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals. Microb Pathog. 2012;53:66-73.
Akbar Ali M, Mirza AH, Butcher RJ, Tarafder MTH, Keat TB, Ali AM. Biological activity of palladium(II) and platinum(II) complexes of the acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate and the X-ray crystal structure of the [Pd(asme)2] (asme=anionic form of the acetone Schiff base of S-methyldithiocarbazat. J Inorg Biochem. 2002;92:141-8.
Brown AW. Recent Developments in the Chemistry of Pyrazoles. In: Advances in Heterocyclic Chemistry. 2018. p. 55-107.
Naim MJ, Alam O, Nawaz F, Alam MJ, Alam P. Current status of pyrazole and its biological activities. Journal of Pharmacy and Bioallied Sciences. 2016;8:2-17.
Khan MF, Alam MM, Verma G, Akhtar W, Akhter M, Shaquiquzzaman M. The therapeutic voyage of pyrazole and its analogs: A review. European Journal of Medicinal Chemistry. 2016;120:170-201.
Siddiqui ZN, Asad M, Praveen S. Synthesis and biological activity of heterocycles from chalcone. In: Medicinal Chemistry Research. 2008. p. 318-25.
Szliszka E, Czuba ZP, Sȩdek Ł, Paradysz A, Król W. Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacol Reports. 2011;63:139-48.
Rajendra Prasad Y, Lakshmana Rao A, Prasoona L, Murali K, Ravi Kumar P. Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2″-hydroxy naphthalen-1″-yl)-1,5-diphenyl-2-pyrazolines. Bioorganic Med Chem Lett. 2005;15:5030-4.
Rojas J, Payá M, Dominguez JN, Luisa Ferrándiz M. The synthesis and effect of fluorinated chalcone derivatives on nitric oxide production. Bioorganic Med Chem Lett. 2002;12:1951-4.
Nowakowska Z, Kedzia B, Schroeder G. Synthesis, physicochemical properties and antimicrobial evaluation of new (E)-chalcones. Eur J Med Chem. 2008;43:707-13.
Viana GSB, Bandeira MAM, Matos FJA. Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva Allemão. Phytomedicine. 2003;10:189-95.
Zhao LM, Jin HS, Sun LP, Piao HR, Quan ZS. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Bioorganic Med Chem Lett. 2005;15:5027-9.
Valla A, Valla B, Cartier D, Le Guillou R, Labia R, Florent L, et al. New syntheses and potential antimalarial activities of new "retinoid-like chalcones. " Eur J Med Chem. 2006;41:142-6.
Jamal H, Ansari WH, Rizvi SJ. Chalcones: Differential effects on glycogen contents of liver, brain and spinal cord in rats. Biol Med. 2009;1:107-15.
Liu M, Wilairat P, Croft SL, Tan ALC, Go ML. Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorganic Med Chem. 2003;11:2729-38.
Satyanarayana M, Tiwari P, Tripathi BK, Srivastava AK, Pratap R. Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines. Bioorganic Med Chem. 2004;12:883-9.
Khatib S, Nerya O, Musa R, Shmuel M, Tamir S, Vaya J. Chalcones as potent tyrosinase inhibitors: The importance of a 2,4-substituted resorcinol moiety. Bioorganic Med Chem. 2005;13:433-41.
Shafiee A, Bagheri M, Shekarchi M, Abdollahi M. The antinociceptive activities of 1-(4-aryl-2-thiazolyl)-3,5-disubstituted-2 pyrazolines in mouse writhing test. J Pharm Pharm Sci. 2003;6:359-61.
Greber G. Vogel's textbook of practical organic chemistry (5th ed. ), revised by Brian S. Furniss, Antony J. Hannaford, Peter W. G. Smith, and Austin R. Tatchell, John Wiley & Sons, New York, 1514 pp. price: $84. 95. J Polym Sci Part A Polym Chem. 1991;29:1223-1223.
Revanasiddappa BC, Rao RN, Subrahmanyam EVS, Satyanarayana D. Synthesis and biological evaluation of some novel 1, 3, 5-trisubstituted pyrazolines. E-Journal Chem. 2010;7:295-8.
Patel VM, Desai KR. Eco-friendly synthesis of fluorine-containing pyrazoline derivatives over potassium carbonate. Arkivoc. 2004;6:123-9.
Chimenti F, Bizzarri B, Manna F, Bolasco A, Secci D, Chimenti P, et al. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives. Bioorganic Med Chem Lett. 2005;15:603-7.
Yoon H, Ahn S, Park M, Kim DW, Kim SH, Koh D, et al. 1H and 13C NMR spectral assignments of chalcones bearing pyrazoline-carbothioamide groups. Magn Reson Chem. 2013;51:500-8.
Kim B, Ahn S, Lee Y, Koh D, Lim Y. 1H and 13C NMR spectral assignments of nineteen 5-(3,5-dimethoxyphenyl)-3-(2-methoxyphenyl)-2-pyrazoline derivatives. Magn Reson Chem. 2021;59:478-88.
How to Cite
Copyright (c) 2022 Al-Mustansiriyah Journal of Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles accepted for publication in Al-Mustansiriyah Journal of Science (MJS) are protected under the Creative Commons Attribution 4.0 International License (CC-BY-NC). Authors of accepted articles are requested to sign a copyright release form prior to their article being published. All authors must agree to the submission, sign copyright release forms, and agree to be included in any correspondence between MJS and the authors before submitting a work to MJS. For personal or educational use, permission is given without charge to print or create digital copies of all or portions of a MJS article. However, copies must not be produced or distributed for monetary gain. It is necessary to respect the copyright of any parts of this work that are not owned by MJS.